Publication | Closed Access

Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study

Breast OncologyVersus Sequential TamoxifenMedicinePhase IiiPharmacologyGynecologyBreast CancerMenopausePharmacotherapyHormone-responsive Breast CancerCancer TreatmentOncologyEndocrine-related CancerWomen's HealthMenopause Hormone Therapy